Skip to content
MARKETS / NYSE / TFX
NYSE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP

Teleflex Inc. TFX

18 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.0B
▲ 17.2% YoY
$-905.6M
▼ 1399.8% YoY
$1.4M
▼ 99.3% YoY
In brief

What this company does

Teleflex primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Its major manufacturing operations are located in the Czech Republic, Malaysia, Mexico and the United States. As of December 31, 2025, it employed approximately 15,500 employees, including 3,700 employees in the U.S. and 11,800 employees in 38 other countries around the world. It has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Teleflex was founded in 1943 as a manufacturer of precision mechanical push/pull controls for military aircraft. Following the divestitures of its marine business and cargo container and systems businesses in 2011, it became exclusively a medical device company.

Written from the business description in TELEFLEX INCORPORATED's annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth
USD 2.0B
Revenue, FY2025 · full 18-year series below
Revenue $B Net income $B
FY2025 · Revenue 2.0 · Net income -0.9
1.0B2.0B-0.4B-0.8B2008201120142017202020232025
Compound annual growth
−10.6%
−4.7%
+1.0%
+2.4%
+0.0%
+0.0%
+0.0%
+0.0%
+78.1%
+41.6%
+20.3%
+13.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −4.7% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−45 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating 5.9% · Net -45.4%
10%20%-20%-40%2008201120142017202020232025
ROE
FY2025 · ROE -24.5%
5%10%15%-10%-20%2008201120142017202020232025

Each USD of equity lost 24 cents this year.

Cash & shareholders
USD 360.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 1.4
200M400M2008201120142017202020232025
Net buybacks $M Dividends $M
FY2025 · Dividends 60.3 · Net buybacks 300.0
200MDividendsNet buybacks2008201120142017202020232025

USD 60.3M in dividends and USD 300.0M in buybacks went back to shareholders in a year without profit.

Total assetsUSD 6.9B
EquityUSD 3.1B
CashUSD 378.6M
Gross debtUSD 2.6B
Net debtUSD 2.3B
Current ratio2.54×

Net debt stands at 72% of equity.

The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 202520242023202220212020201920182017201620152014201320122011201020092008
Revenue $B2.01.71.72.82.82.52.62.42.11.91.81.81.71.61.51.41.41.9
Operating income $B0.10.10.30.50.60.40.40.30.40.30.30.30.2−0.10.20.20.30.2
EBITDA $B0.20.20.30.60.70.50.50.40.40.40.40.30.3−0.10.30.30.30.3
Income tax $B−0.0−0.00.00.10.10.0−0.10.00.10.00.00.00.00.00.00.00.00.0
Net income $B−0.90.10.40.40.50.30.50.20.20.20.20.20.2−0.20.30.20.30.1
Free cash flow $B0.00.20.20.30.60.30.30.40.40.40.20.20.20.10.00.10.10.1
EPS, diluted $−20.251.487.537.6810.237.099.804.293.274.985.104.043.45−4.657.924.997.593.01
Dividend / sh $1.361.361.361.361.361.361.361.361.361.361.361.361.361.361.361.361.361.34
Payout %−7911818131914314025233037−2917271844
ROE %−24.51.68.49.313.710.616.78.16.711.412.59.88.2−10.117.212.019.2·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 88 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 7 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2008

Share this section

Download image